Glenmark Pharma gets USFDA nod for diabetes management drug

"Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food & Drug Administration (USFDA) for metformin hydrochloride extended release tablets USP, 500 mg and 1000 mg, the generic version of Glumetza extended release tablets, 500 mg and 1,000 mg, of Salix Pharmaceuticals Inc," the drug maker said in a filing to BSE.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2rnOCW6
via IFTTT